Event Details

Friday, 19 May 2017
12:00 pm - 12:45 pm
UQ Location:
Human Movement Studies Building (St Lucia)
Event category(s):

Event Contact

Ms Sandrine Kingston-Ducrot
3365 6912
Org. Unit:
Human Movement and Nutrition Sciences

Event Description

Full Description:
Up to 1/3 of adults in Australia have non-alcoholic fatty liver disease (NAFLD). NAFLD is characterized by excess liver fat and is strongly linked with type 2 diabetes and cardiovascular disease.
As there are currently no accepted pharmacological agents for the long-term management of NAFLD, lifestyle therapy is at the forefront of management.
A current issue in NAFLD management is that accurate quantification of liver fat via proton magnetic resonance spectroscopy (1H-MRS) is expensive (~$600/hr). Novel indices based on simple blood and anthropometric markers have been proposed for the prediction of liver fatness.
This talk will present findings from Dr Keating’s recent work examining the accuracy of these indices. These findings have implications for researchers and clinicians seeking to determine the efficacy of interventions using these biomarkers.

Dr Shelley Keating is an NHMRC Early Career Fellow at the School of Human Movement and Nutrition Sciences, The University of Queensland.

Directions to UQ

Google Map:
To St Lucia Campus, UQ Ipswich, and UQ Gatton.

Event Tools

Share This Event

Print this Article Print

Print this Article Email

Share this Article Share

Rate This Event

Tweet This Event

Export This Event

Export calendar

Calendar Tools

Filter by Keywords/Dates

Featured Calendars

Subscribe via RSS